Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2024.03.29
ag真人平台官方：关于公司2023年计提资产减值准备的公告
2024.03.29
ag真人平台官方：关于独立第三方调查结果的公告
2024.03.29
ag真人平台官方：关于2024年度向银行申请授信额度暨提供担保的公告
2024.03.29
ag真人平台官方：第六届董事会第九次会议决议公告
2024.03.29
ag真人平台官方：2023年年度股东大会通知
2024.03.29
ag真人平台官方：2023年年度报告摘要
2024.03.29
ag真人平台官方：2023年年度报告
2024.03.15
ag真人平台官方：关于收到实际控制人先行垫付款项的公告
2024.03.15
DATE OF BOARD MEETING
2024.03.15
INSIDE INFORMATION ANNOUNCEMENT
第一页
上一页
11
12
13
14
15
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
